Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2004

View Archived Issues

Sinovac gains approval for clinical trial on SARS vaccine

Advanced Magnetics reports Q1 R&D highlights

Two routes of administration tested for misoprostol in the termination of early pregnancy

Aspirin and vitamin E in the prevention of cardiovascular events in type 2 diabetes

Ezetimibe reported to increase the effects of simvastatin in primary hypercholesterolemia

Lower incidence of atrial fibrillation associated with statin use in patients with chronic CAD

Finasteride superior to saw palmetto in chronic prostatitis/chronic pelvic pain syndrome

Novel porphyrins with SOD activity developed at Duke University

New 5-HT2C agonists and their use reported by Wyeth

Forbes Medi-Tech claims androstane-ascorbate conjugates in a recent patent

New antibacterial agents targeting DXP reductoisomerase claimed by Karo Bio

Sanofi-Synthelabo presents new inhibitors of neurotrophin p75 receptors

Novel inhibitors of ICAM/leukointegrin interaction under study at Boehringer Ingelheim

New p38 MAP kinase inhibitors in early development at Merck

Novel histamine H3 receptor ligands discovered by Novo Nordisk team

Chymase inhibitors prevent intraperitoneal adhesion formation in hamsters

IMMU-110 shows promising results in a B-lymphoma animal model

Epigallocatechin-3 gallate inhibits VEGF-induced angiogenesis in vitro

German approval for three-month Eligard

Biovitrum to be sole supplier of ReFacto

Ikomio ALS trial cleared to continue

Argenta enters new contract research agreement with GlaxoSmithKline

Bioequivalence demonstrated for intravenous and subcutaneous Remodulin

Zentaris and Solvay to advance LHRH antagonists through collaboration

APF-112 phase II trial progresses

Wyeth files IND for compound originating from ArQule collaboration

PDL receives licenses fees for Xolair and Raptiva

Atiprimod granted orphan drug status for multiple myeloma

Landmark year at Britannia

HemispheRx Biopharma announces joint West Nile virus clinical program

Generex Biotechnology initiates study for peri-oral delivery of Oroferone

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...